A new, noninvasive nuclear medicine test can be used to determine whether aromatase inhibitor treatment will be effective for specific cancer patients, according to a recent study reported in The Journal of Nuclear Medicine.
Noninvasive nuclear medicine test can help determine effectiveness of aromatase inhibitor treatment
↧
↧
